oasis 1 trial oral semaglutide 50 mg obesity nejm 2023 25 Demonstrates Substantial Weight Loss in Adults with Overweight or Obesity: Results from oasis 1 trial oral semaglutide

Additionally, patient demographics such as other or unknown race and missing sex in datasets can impact study findings and generalizability

Assessment of sex differences in fracture risk among patients with anorexia nervosa: a population-based cohort study using the health improvement network

Immune Boost Enhances antioxidant capacity and promotes cell health

International Travel: Recent travel outside of the United States or Canada, especially to areas where malaria or other endemic diseases are found, can result in a temporary deferral

I am sure molecular evaluation is already done

Sustained energy: The energy improvements should be consistent rather than fluctuating